Kyle Gano - Nov 1, 2024 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Executive Officer, Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Stock symbol
NBIX
Transactions as of
Nov 1, 2024
Transactions value $
$0
Form type
4
Date filed
11/1/2024, 07:52 PM
Previous filing
Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Restricted Stock Unit Award $0 +2.46K $0.00 2.46K Nov 1, 2024 Common Stock 2.46K Direct F1, F2
transaction NBIX Stock Option Award $0 +13.3K $0.00 13.3K Nov 1, 2024 Common Stock 13.3K $122.21 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F2 The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of November 1, 2025, November 1, 2026, November 1, 2027, and November 1, 2028.
F3 Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on December 1, 2024 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.